JTC PLC (JTCPF)
OTCMKTS · Delayed Price · Currency is USD
11.30
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT

Theseus Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
2,1052,0131,6751,3041,775917
Upgrade
Market Cap Growth
20.18%20.18%28.45%-26.55%93.61%47.93%
Upgrade
Enterprise Value
2,4142,2421,7631,4681,8651,054
Upgrade
Last Close Price
11.3013.0010.359.2512.00-
Upgrade
PE Ratio
--60.2731.1849.2063.76
Upgrade
PS Ratio
5.515.275.115.418.895.84
Upgrade
PB Ratio
3.153.012.612.703.804.24
Upgrade
P/FCF Ratio
22.4221.4416.6621.5047.7125.77
Upgrade
P/OCF Ratio
21.3620.4316.1820.3045.4324.35
Upgrade
EV/Sales Ratio
5.975.875.386.099.346.71
Upgrade
EV/EBITDA Ratio
21.0322.7420.0323.7057.8827.29
Upgrade
EV/EBIT Ratio
30.2029.9026.0431.9699.6137.36
Upgrade
EV/FCF Ratio
25.7123.8817.5424.2050.1229.63
Upgrade
Debt / Equity Ratio
0.610.610.530.500.570.95
Upgrade
Debt / EBITDA Ratio
3.743.743.543.446.694.59
Upgrade
Debt / FCF Ratio
4.314.313.363.947.135.76
Upgrade
Asset Turnover
0.320.320.330.310.300.36
Upgrade
Quick Ratio
1.361.362.163.002.802.91
Upgrade
Current Ratio
1.431.432.253.162.913.11
Upgrade
Return on Equity (ROE)
-1.40%-1.40%4.83%9.32%10.60%7.34%
Upgrade
Return on Assets (ROA)
3.89%3.89%4.20%3.67%1.76%3.98%
Upgrade
Return on Capital (ROIC)
4.61%4.61%4.86%4.18%2.04%4.65%
Upgrade
Return on Capital Employed (ROCE)
6.80%6.80%6.40%6.00%2.40%6.20%
Upgrade
Earnings Yield
-0.43%-0.45%1.66%3.21%2.03%1.57%
Upgrade
FCF Yield
4.46%4.66%6.00%4.65%2.10%3.88%
Upgrade
Dividend Yield
-1.21%1.38%1.30%0.86%-
Upgrade
Payout Ratio
--73.44%34.12%34.12%67.84%
Upgrade
Buyback Yield / Dilution
-5.29%-5.29%-5.46%-11.55%-12.12%-5.10%
Upgrade
Total Shareholder Return
-5.29%-4.08%-4.09%-10.25%-11.25%-5.10%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.